According to the latest report by IMARC Group, “Global Stretch Marks Treatment Market Share, Size, Growth, Industry Trends, Opportunity and Forecast 2023-2028“, the global stretch marks treatment market size reached US$ 2.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.1 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.
Stretch marks, striae or striae distensae (SD), are caused by stretch or shrinking of the skin due to pregnancy, muscle growth, weight loss or gain, and obesity with unexpected changes in the body. Some commonly known stretch mark treatment solutions include lotions, creams, oils and serums, hyaluronic acid, tretinoin, pulse-dye lasers, fractional lasers, micro-needling, and microdermabrasion. They help minimize the visibility of stretch marks by reconstructing collagen for tightening the skin and treating fine lines and open pores. As a result, stretch marks treatment is widely adopted in clinics, hospitals, home use, and specialty dermatology centers.
Request Free Sample Report: https://www.imarcgroup.com/stretch-marks-treatment-market/requestsample
The market is primarily driven by rising concerns regarding the aesthetic appearance of individuals and expanding healthcare infrastructure across the globe. In addition, the growing consumption of ready-to-eat (RTE) fast food, hectic work schedules, increasing disposable income, and the growing prevalence of unhealthy lifestyles among working professionals are leading to obesity, thus contributing to market growth. Moreover, the introduction of platelet-rich plasma (PRP), non-invasive microdermabrasion, laser-based treatment procedures, and micro-needling that help to break down old collagen and encourage the development of new skin tissues represent another major growth-inducing factor.
Besides this, the widespread adoption of laser treatment on account of increasing demand for quick, efficient, less invasive treatment options that offer smooth and better-looking skin is also providing a positive thrust to the market growth. Furthermore, the easy availability of over-the-counter stretch mark ointments, and research and development (R&D) activities, and mergers and acquisitions (M&A) among leading players are also creating a favorable market outlook.
Global Stretch Marks Treatment Market 2023-2028 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Stretch Marks Treatment Companies:
Clarins, Dermaclara, E.T. Browne Drug Co. Inc., Helix Biomedix Inc., HRA Pharma (Perrigo Company plc), Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Laboratoires Expanscience, Union-Swiss (Pty) Ltd and Weleda.
The report has segmented the market on the basis of treatment, distribution channel, end user and region.
Breakup by Treatment:
- Topical Products
- Oils and Serum
- Fractional Lasers
- Pulse-Dye Lasers
Breakup by Distribution Channel:
- Supermarkets and Hypermarkets
- Specialist Retailers
- Medical Retailers
- Online Stores
Breakup by End User:
- Hospitals and Clinics
- Home Use
- Specialty Dermatology Centers
Breakup by Region:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Ask an Analyst: https://www.imarcgroup.com/request?type=report&id=5405&flag=C
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal